What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Alzheimer's disease
Philip Scheltens spends much of his time researching Dementia, Alzheimer's disease, Pathology, Neuroscience and Internal medicine.
His research integrates issues of Psychiatry and Atrophy in his study of Dementia.
His research in Psychiatry intersects with topics in Age of onset, Pediatrics and Cognitive decline.
His work in Alzheimer's disease addresses issues such as Apolipoprotein E, which are connected to fields such as Bioinformatics.
His Pathology research is multidisciplinary, incorporating elements of Neurology, Magnetic resonance imaging and Central nervous system disease.
Philip Scheltens has researched Internal medicine in several fields, including Gastroenterology, Endocrinology, Oncology and Cardiology.
His most cited work include:
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease (9237 citations)
- Consistent resting-state networks across healthy subjects (3280 citations)
- Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria (3224 citations)
What are the main themes of his work throughout his whole career to date?
Philip Scheltens mostly deals with Dementia, Disease, Internal medicine, Pathology and Alzheimer's disease.
His Dementia research includes themes of Psychiatry, Cognition, Cohort and Atrophy.
The various areas that Philip Scheltens examines in his Disease study include Neurology, Neuroscience and Gerontology.
His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology, Oncology and Cardiology.
His studies deal with areas such as Magnetic resonance imaging and Central nervous system disease as well as Pathology.
His study connects Degenerative disease and Alzheimer's disease.
He most often published in these fields:
- Dementia (35.62%)
- Disease (30.67%)
- Internal medicine (29.14%)
What were the highlights of his more recent work (between 2018-2021)?
- Dementia (35.62%)
- Disease (30.67%)
- Internal medicine (29.14%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Dementia, Disease, Internal medicine, Cognitive decline and Cognition.
His Dementia research focuses on subjects like Neurology, which are linked to Positron emission tomography.
His Disease research incorporates themes from Neuroscience, Atrophy and Bioinformatics.
His Internal medicine research includes themes of Oncology and Cardiology.
His Oncology research integrates issues from Stage and Neuroimaging.
He has researched Cognitive decline in several fields, including Gastroenterology, Executive functions, Hyperintensity and Hazard ratio.
Between 2018 and 2021, his most popular works were:
- Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia (73 citations)
- Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype (49 citations)
- The “rights” of precision drug development for Alzheimer’s disease (44 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Alzheimer's disease
Dementia, Disease, Cognitive decline, Internal medicine and Cognition are his primary areas of study.
His research in Dementia intersects with topics in Alzheimer's disease, Neurology, Gastroenterology and Gerontology.
The various areas that Philip Scheltens examines in his Alzheimer's disease study include Frontotemporal dementia and Bioinformatics.
His Disease study integrates concerns from other disciplines, such as Biomarker, TREM2, Genome-wide association study and Audiology.
His studies in Cognitive decline integrate themes in fields like Hyperintensity, Amyloid beta, Neuropsychology, Executive functions and Atrophy.
His Internal medicine study combines topics from a wide range of disciplines, such as Oncology and Cardiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
